Nomura Holdings’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,170
Closed -$665K 1494
2023
Q2
$665K Buy
+16,170
New +$778K ﹤0.01% 1006
2021
Q2
Sell
-18,460
Closed -$1.27M 2160
2021
Q1
$1.27M Buy
+18,460
New +$1.25M ﹤0.01% 1009
2018
Q2
Sell
-4,350
Closed -$241 1404
2018
Q1
$241 Buy
+4,350
New +$228K ﹤0.01% 1328
2017
Q2
Sell
-8,242
Closed -$347K 1523
2017
Q1
$347K Buy
+8,242
New +$352K ﹤0.01% 1040
2016
Q4
Sell
-2,508
Closed -$104K 1595
2016
Q3
$104K Sell
2,508
-1,092
-30% -$45.7K ﹤0.01% 1096
2016
Q2
$144K Sell
3,600
-554
-13% -$19.9K ﹤0.01% 1075
2016
Q1
$139K Sell
4,154
-9,048
-69% -$282K ﹤0.01% 1337
2015
Q4
$447K Buy
+13,202
New +$413K ﹤0.01% 1148
2015
Q3
Sell
-3,129
Closed -$84K 1786
2015
Q2
$84K Buy
+3,129
New +$83.4K ﹤0.01% 1687
2014
Q2
Sell
-10,877
Closed -$205K 2871
2014
Q1
$205K Buy
+10,877
New +$210K ﹤0.01% 2323

Other funds holding IART

Nomura Holdings's IART Position: Q3 2023 in Review

Nomura Holdings sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 16,170 shares — an estimated $665K sold.

Nomura Holdings first reported a position in IART in Q1 2014 and held it in 10 quarters. The position peaked at $1.27M in Q1 2021. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Nomura Holdings reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Nomura Holdings sold 16,170 Integra LifeSciences shares in Q3 2023, an estimated $665K.
  • Nomura Holdings first reported a position in Integra LifeSciences in Q1 2014 and held it in 10 quarters.
  • Nomura Holdings's Integra LifeSciences position peaked at $1.27M in Q1 2021.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Nomura Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.